Are We Missing the Beat When Tackling Rising Rates of Heart Conditions?

Multiple factors are known to affect the cardiovascular system and contribute to the standard risk factors for atheroscl...

January 24, 2024 | Wednesday | Analysis
New approaches to treat diverse bile duct cancers prevalent in Southeast Asia

An international study led by the National Cancer Centre Singapore (NCCS) and Duke-NUS Medical School has effectively ta...

January 24, 2024 | Wednesday | News
Singapore paves way for therapies to maintain mental well-being of ageing individual

A team of scientists from Nanyang Technological University, Singapore (NTU Singapore) has demonstrated that commun...

January 22, 2024 | Monday | News
Molecular Diagnostics may offer Hope for Cancer Drug Shortages in Asia

Projections by the International Agency for Research on Cancer estimate 15.1 million new cases per year, until 2040. Thi...

January 19, 2024 | Friday | Opinion
Safeguarding Artificial Womb Technology: An analytical perspective around Singapore's Medical landscape

In recent years, there is an increasing occurrence of premature births in Singapore that requires warding in highly-expe...

January 17, 2024 | Wednesday | Opinion
VirtualiSurg Mediverse accelerates training for surgery and health-tech sectors globally

Paris-headquartered international medtech firm, VirtualiSurg has created an immersive mediverse – a virtual learni...

January 17, 2024 | Wednesday | News
Singapore's TVM Capital Healthcare invests in Vietnamese Eye Care Business Alina Vision

The Fred Hollows Foundation, Australia, Rohto Pharmaceutical, Japan, and TVM Capital Healthcare, S...

January 16, 2024 | Tuesday | News
Singapore's SIT launches Innovative Healthcare Programmes to empower nursing profession

As Singapore faces a rapidly ageing population and a growing burden of chronic and complex health conditions, the need t...

January 16, 2024 | Tuesday | News
Zuellig Pharma & Substipharm Biologics expand access to Japanese Encephalitis vaccine across Asia

Singapore-based Zuellig Pharma has announced its commercialisation partnership with French pharmaceutical company Substi...

January 16, 2024 | Tuesday | News
Qatar-based startup Droobi Health merges with India’s Smit.fit to form DroobiSmit

Droobi Health, a digital diabetes player in the Middle East from Qatar, and Smit.fit, a frontrunner in India’s dig...

January 16, 2024 | Tuesday | News
Singapore evaluates 'Innovation Enhancing Techniques' (IETs) to tackle healthcare-biomedicine R&D and entrepreneurship barriers

Researchers from Singapore's Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and the Un...

January 15, 2024 | Monday | Analysis
Singapore’s IWHP researchers at NUH and NUS Medicine reveal menopausal arthralgia prophylaxis

Women in their mid-50s faces a cascade of menopausal symptoms. Among them, arthralgia —muscular and joint pain &md...

January 12, 2024 | Friday | Company results
Singapore's Health Ministry lays focus on manpower planning for future national crises

The Ministry of Health (MoH), Public Service Division (PSD), and the Singapore Airlines (SIA) Group have signed a Memora...

January 15, 2024 | Monday | News
ClinChoice acquires CSI, expanding global footprint into Southeast Asia

ClinChoice, a global Contract Research Organisation (CRO), has announced expanding its global footprint with the acquisi...

January 12, 2024 | Friday | News
Enterprise Singapore & A*STAR upholds Singapore's promising biomedical companies at JPM 2024 Conference

The 42nd Annual Healthcare Conference was held on January 8-11, 2024 in San Francisco, CA. Global industry leaders, fast...

January 12, 2024 | Friday | News
Rethinking pharmacovigilance efficiencies amidst APAC's diverse regulatory landscape and rising drug development costs

Globally, the pursuit for treatments with better patient outcomes and more effective care is a never-ending quest. As di...

January 11, 2024 | Thursday | Analysis
Novel CAR T-cell therapy regimen to augment oncology care for hard-to-treat cancers

Kite Pharma, a Gilead Company, is a global biopharmaceutical company specializing in cancer cell therapy As the global c...

January 11, 2024 | Thursday | Opinion
Biotech and Biopharma Industry Trends: What to Watch for in 2024

Emerging biotech and biopharma (EBP) companies continue to drive global medical innovation, with Asia Pacific playing a ...

January 10, 2024 | Wednesday | Opinion